Please enable JavaScript or talk to your local administrator to get JavaScript enabled.

Project

Unraveling disparate roles of Notch-1 and Notch-2 signaling in bladder cancer.

Funder: Michael Smith Foundation for Health Research

Funding period
CAD 450 K
USD 345 K
Funding amount
Abstract



OBJECTIVE. Bladder cancer is the 5th most common cancer, yet it remains understudied and we are only now making strides in understanding the molecular make-up of this cancer. Recently we and others have discovered that loss of the cell surface receptor Notch-1 drives growth of some bladder cancers, while increased Notch-2 activity drives other bladder cancers. Here we aim to determine how Notch-1 and Notch-2 can lead to such differing effects on cancer growth even though they share many features in common. In addition we aim to design a new drug to inhibit Notch-2 specifically.

SPECIFIC AIMS. To address these objectives, we propose three specific aims:

In our Aim #1 we will create a mouse model that over-expresses Notch-2 specifically in the bladder and we expect this will cause bladder tumours to form. 

In our Aim #2 we will use advanced techniques to study the differences between Notch-1 and Notch- 2 signaling that make them have such different effects. Here we will especially investigate how each Notch protein controls the reading of genes in the cell nucleus.

In the Aim #3 we will develop a new small molecule inhibitor of Notch-2 using computer-aided drug design.


Similar projects All >
Sorted by: Start Date
Project list item
Dissecting myeloid cell-mediated resistance to immune checkpoint blockade in bladder cancer

National Cancer Institute to NINA BHARDWAJ, MATTHEW GALSKY, JUN ZHU

USD 703,400
2020 - 2025
Project list item
Chimeric RNAs and their implication in lymphatic metastasis of bladder cancer

National Cancer Institute to HUI LI

USD 205,913
2020 - 2025
Project list item
CD40 agonism for the treatment of bladder cancer

National Cancer Institute to CHRISTOPHER STUART GARRIS

USD 64,554
2020 - 2023
Project list item
Effect of APOBEC3 on Bladder Cancer Biology and Response to Immunotherapy

National Cancer Institute to ANDREW TRUONG

USD 45,016
2020 - 2023
Project list item
A new bladder cancer model based on tissue reprogramming and gene targeting

National Cancer Institute to FLAMINIA TALOS, DAIFENG WANG

USD 203,843
2020 - 2021

System

Categories
  • FOR (ANZSRC)

    1112 Oncology and Carcinogenesis

  • RCDC

    Cancer

  • RCDC

    Urologic Diseases

  • HRCS HC

    Cancer

  • HRCS RAC

    2.1 Biological and endogenous factors

  • HRCS RAC

    5.1 Pharmaceuticals

  • Health Research Areas

    Biomedical

  • Broad Research Areas

    Basic Science